Review of the Microscopic Colitides

Article

Abstract

Microscopic colitis is a common cause of chronic diarrhea in predominantly older adults. Incidence rates of microscopic colitis (including lymphocytic and collagenous colitis) have increased over time to levels comparable to other forms of inflammatory bowel disease. The possibility of drug-induced microscopic colitis is an important consideration when evaluating these patients, although this concept requires further investigation. There are few controlled treatment trials in microscopic colitis, with much of the data on treatment coming from retrospective studies. In patients with microscopic colitis, a systematic approach to therapy often leads to satisfactory control of symptoms. In this review, we will provide an updated assessment of the epidemiology, diagnosis, and treatment of microscopic colitis.

Keywords

Microscopic colitis Collagenous colitis Lymphocytic colitis 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Pardi DS, Loftus Jr EV, Smyrk TC, et al. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut. 2007;56:504–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Fernandez-Banares F, Salas A, Forne M, et al. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol. 1999;94:418–23.PubMedGoogle Scholar
  3. 3.
    Williams JJ, Kaplan GG, Makhija S, et al. Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol. 2008;6:35–40.PubMedCrossRefGoogle Scholar
  4. 4.
    Loftus Jr EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–17.PubMedCrossRefGoogle Scholar
  5. 5.
    Limsui D, Pardi DS, Camilleri M, et al. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis. 2007;13:175–81.PubMedCrossRefGoogle Scholar
  6. 6.
    • Chey WD, Nojkov B, Rubenstein JH, et al. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol. 105:859–65. The first study to prospectively evaluate the yield of colonoscopy in patients with irritable bowel syndrome symptoms, with 2.3% of patients over age 45 being diagnosed with microscopic colitis. Google Scholar
  7. 7.
    Yen EF, Pokhrel B, Bianchi LK, et al. Concomitant adenoma rates in patients with microscopic colitis. Gastroenterology. 2009;136:A-20.CrossRefGoogle Scholar
  8. 8.
    Olesen M, Eriksson S, Bohr J, et al. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut. 2004;53:536–41.PubMedCrossRefGoogle Scholar
  9. 9.
    Agnarsdottir M, Gunnlaugsson O, Orvar KB, et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci. 2002;47:1122–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis in Orebro, Sweden, an epidemiological study 1984–1993. Gut. 1995;37:394–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut. 1996;39:846–51.PubMedCrossRefGoogle Scholar
  12. 12.
    Gremse DA, Boudreaux CW, Manci EA. Collagenous colitis in children. Gastroenterology. 1993;104:906–9.PubMedGoogle Scholar
  13. 13.
    Madisch A, Heymer P, Voss C, et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorectal Dis. 2005;20:312–6.PubMedCrossRefGoogle Scholar
  14. 14.
    • Hjortswang H, Tysk C, Bohr J, et al. Health-related quality of life is impaired in active collagenous colitis. Dig Liver Dis. 2010;43:102–9. A cross sectional study with 116 patients with collagenous colitis, the first major paper to illustrate the extent of quality of life impairment in patients with microscopic colitis. PubMedCrossRefGoogle Scholar
  15. 15.
    Baert F, Wouters K, D’Haens G, et al. Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut. 1999;45:375–81.PubMedCrossRefGoogle Scholar
  16. 16.
    • Miehlke S, Heymer P, Bethke B, et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology. 2002;123:978–84.PubMedCrossRefGoogle Scholar
  17. 17.
    • Bonderup OK, Hansen JB, Birket-Smith L, et al. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut. 2003;52:248–51.PubMedCrossRefGoogle Scholar
  18. 18.
    • Baert F, Schmit A, D’Haens G, et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology. 2002;122:20–5.PubMedCrossRefGoogle Scholar
  19. 19.
    • Miehlke S, Madisch A, Karimi D, et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology. 2009;136:2092–100. The preceding four studies (16–19) represent the largest randomized placebo-controlled studies to date on the treatment of microscopic colitis, all using budesonide. PubMedCrossRefGoogle Scholar
  20. 20.
    • Miehlke S, Madisch A, Bethke B, et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2008;135:1510–6.PubMedCrossRefGoogle Scholar
  21. 21.
    • Bonderup OK, Hansen JB, Teglbjaerg PS, et al. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut. 2009;58:68–72. The preceding 2 studies are placebo-controlled studies involving budesonide for maintenance of remission in microscopic colitis. PubMedCrossRefGoogle Scholar
  22. 22.
    Chan JL, Tersmette AC, Offerhaus GJ, et al. Cancer risk in collagenous colitis. Inflamm Bowel Dis. 1999;5:40–3.PubMedCrossRefGoogle Scholar
  23. 23.
    Kao KT, Pedraza BA, McClune AC, et al. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol. 2009;15:3122–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Pardi DS, Ramnath VR, Loftus Jr EV, et al. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol. 2002;97:2829–33.PubMedCrossRefGoogle Scholar
  25. 25.
    Wolber R, Owen D, Freeman H. Colonic lymphocytosis in patients with celiac sprue. Hum Pathol. 1990;21:1092–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Green PH, Yang J, Cheng J, et al. An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol. 2009;7:1210–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Bohr J, Tysk C, Yang P, et al. Autoantibodies and immunoglobulins in collagenous colitis. Gut. 1996;39:73–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Fine KD, Do K, Schulte K, et al. High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome. Am J Gastroenterol. 2000;95:1974–82.PubMedCrossRefGoogle Scholar
  29. 29.
    Pardi DS, Loftus Jr EV, Kammer PP, et al. Collagenous colitis, but not lymphocytic colitis, is associated with cigarette smoking [abstract]. Am J Gastroenterol. 2004;99:S116.CrossRefGoogle Scholar
  30. 30.
    Pokhrel B, Witt B, Bianchi LK, et al. Microscopic colitis and association with cigarette smoking and alcohol intake [abstract]. Am J Gastroenterol. 2009;104:S453–4.Google Scholar
  31. 31.
    Jarnerot G, Tysk C, Bohr J, et al. Collagenous colitis and fecal stream diversion. Gastroenterology. 1995;109:449–55.PubMedCrossRefGoogle Scholar
  32. 32.
    Mosnier JF, Larvol L, Barge J, et al. Lymphocytic and collagenous colitis: an immunohistochemical study. Am J Gastroenterol. 1996;91:709–13.PubMedGoogle Scholar
  33. 33.
    Beaugerie L, Pardi DS. Review article: drug-induced microscopic colitis—proposal for a scoring system and review of the literature. Aliment Pharmacol Ther. 2005;22:277–84.PubMedCrossRefGoogle Scholar
  34. 34.
    Fernandez-Banares F, Esteve M, Espinos JC, et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol. 2007;102:324–30.PubMedCrossRefGoogle Scholar
  35. 35.
    Riddell RH, Tanaka M, Mazzoleni G. Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut. 1992;33:683–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Bjarnason I, Hayllar J, MacPherson AJ, et al. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology. 1993;104:1832–47.PubMedGoogle Scholar
  37. 37.
    Yagi K, Nakamura A, Sekine A, et al. Nonsteroidal anti-inflammatory drug-associated colitis with a histology of collagenous colitis. Endoscopy. 2001;33:629–32.PubMedCrossRefGoogle Scholar
  38. 38.
    Al-Ghamdi MY, Malatjalian DA, Veldhuyzen van Zanten S. Causation: recurrent collagenous colitis following repeated use of NSAIDs. Can J Gastroenterol. 2002;16:861–2.PubMedGoogle Scholar
  39. 39.
    Pascua MF, Kedia P, Weiner M, et al. Microscopic colitis and medication use. Gastroenterology. 2009;136:A-366.CrossRefGoogle Scholar
  40. 40.
    Pignone M, Anderson GK, Binns K, et al. Aspirin use among adults aged 40 and older in the United States: results of a national survey. Am J Prev Med. 2007;32:403–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Lundberg JO, Herulf M, Olesen M, et al. Increased nitric oxide production in collagenous and lymphocytic colitis. Eur J Clin Invest. 1997;27:869–71.PubMedCrossRefGoogle Scholar
  42. 42.
    Olesen M, Middelveld R, Bohr J, et al. Luminal nitric oxide and epithelial expression of inducible and endothelial nitric oxide synthase in collagenous and lymphocytic colitis. Scand J Gastroenterol. 2003;38:66–72.PubMedCrossRefGoogle Scholar
  43. 43.
    Perner A, Andresen L, Normark M, et al. Expression of nitric oxide synthases and effects of L-arginine and L-NMMA on nitric oxide production and fluid transport in collagenous colitis. Gut. 2001;49:387–94.PubMedCrossRefGoogle Scholar
  44. 44.
    Burgel N, Bojarski C, Mankertz J, et al. Mechanisms of diarrhea in collagenous colitis. Gastroenterology. 2002;123:433–43.PubMedCrossRefGoogle Scholar
  45. 45.
    Marteau P, Lavergne-Slove A, Lemann M, et al. Primary ileal villous atrophy is often associated with microscopic colitis. Gut. 1997;41:561–4.PubMedCrossRefGoogle Scholar
  46. 46.
    Ung KA, Gillberg R, Kilander A, et al. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut. 2000;46:170–5.PubMedCrossRefGoogle Scholar
  47. 47.
    Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut. 2003;52:523–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–11.PubMedCrossRefGoogle Scholar
  49. 49.
    Aigner T, Neureiter D, Muller S, et al. Extracellular matrix composition and gene expression in collagenous colitis. Gastroenterology. 1997;113:136–43.PubMedCrossRefGoogle Scholar
  50. 50.
    Salas A, Fernandez-Banares F, Casalots J, et al. Subepithelial myofibroblasts and tenascin expression in microscopic colitis. Histopathology. 2003;43:48–54.PubMedCrossRefGoogle Scholar
  51. 51.
    Lee E, Schiller LR, Vendrell D, et al. Subepithelial collagen table thickness in colon specimens from patients with microscopic colitis and collagenous colitis. Gastroenterology. 1992;103:1790–6.PubMedGoogle Scholar
  52. 52.
    Couto G, Bispo M, Barreiro P, et al. Unique endoscopy findings in collagenous colitis. Gastrointest Endosc. 2009;69:1186–8.PubMedCrossRefGoogle Scholar
  53. 53.
    • Carmack SW, Lash RH, Gulizia JM, et al. Lymphocytic disorders of the gastrointestinal tract: a review for the practicing pathologist. Adv Anat Pathol. 2009;16:290–306. A thorough update of the etiologies of lymphocytic infiltration in the GI tract, reviewing that intra-epithelial lymphocytes can be associated with conditions other than microscopic colitis. PubMedCrossRefGoogle Scholar
  54. 54.
    Fine KD, Lee EL, Meyer RL. Colonic histopathology in untreated celiac sprue or refractory sprue: is it lymphocytic colitis or colonic lymphocytosis? Hum Pathol. 1998;29:1433–40.PubMedCrossRefGoogle Scholar
  55. 55.
    Matteoni CA, Wang N, Goldblum JR, et al. Flexible sigmoidoscopy for the detection of microscopic colitis. Am J Med. 2000;108:416–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Tanaka M, Mazzoleni G, Riddell RH. Distribution of collagenous colitis: utility of flexible sigmoidoscopy. Gut. 1992;33:65–70.PubMedCrossRefGoogle Scholar
  57. 57.
    Thijs WJ, van Baarlen J, Kleibeuker JH, et al. Microscopic colitis: prevalence and distribution throughout the colon in patients with chronic diarrhoea. Neth J Med. 2005;63:137–40.PubMedGoogle Scholar
  58. 58.
    Yen EF, Hall CR, Witt B. Yield of sigmoid and rectal biopsies in the detection of microscopic colitis. Gastroenterology. 2010;138:S638.Google Scholar
  59. 59.
    Fine KD, Lee EL. Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology. 1998;114:29–36.PubMedCrossRefGoogle Scholar
  60. 60.
    Fernandez-Banares F, Esteve M, Salas A, et al. Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea. Dig Dis Sci. 2001;46:2231–8.PubMedCrossRefGoogle Scholar
  61. 61.
    Calabrese C, Fabbri A, Areni A, et al. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial. J Gastroenterol Hepatol. 2007;22:809–14.PubMedCrossRefGoogle Scholar
  62. 62.
    Abdalla AA, Faubion WA, Loftus Jr EV, et al. The natural history of microscopic colitis treated with corticosteroids [abstract]. Gastroenterology. 2008;134:A121.CrossRefGoogle Scholar
  63. 63.
    Munck LK, Kjeldsen J, Philipsen E, et al. Incomplete remission with short-term prednisolone treatment in collagenous colitis: a randomized study. Scand J Gastroenterol. 2003;38:606–10.PubMedCrossRefGoogle Scholar
  64. 64.
    Pardi DS, Loftus Jr EV, Tremaine WJ, et al. Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine. Gastroenterology. 2001;120:1483–4.PubMedCrossRefGoogle Scholar
  65. 65.
    Rodriguez E, Mahadevan U. Anti-TNF therapy for refractory microscopic colitis. Gastroenterology. 2009;136:A663.CrossRefGoogle Scholar
  66. 66.
    Jarnerot G, Bohr J, Tysk C, et al. Faecal stream diversion in patients with collagenous colitis. Gut. 1996;38:154–5.PubMedCrossRefGoogle Scholar
  67. 67.
    Williams RA, Gelfand DV. Total proctocolectomy and ileal pouch anal anastomosis to successfully treat a patient with collagenous colitis. Am J Gastroenterol. 2000;95:2147.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Division of GastroenterologyUniversity of Chicago Pritzker School of Medicine, NorthShore University HealthSystemEvanstonUSA
  2. 2.Inflammatory Bowel Disease Clinic, Division of Gastroenterology and HepatologyMayo Clinic College of MedicineRochesterUSA

Personalised recommendations